L'Oreal Doubles Stake in Swiss Skincare Company Galderma

Dow Jones

2025/12/08

By Sarah Sloat

L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology.

Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said.

The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year.

The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion.

L'Oreal said it wasn't planning to further increase its stake.

Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table.

Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT.

Write to Sarah Sloat at sarah.sloat@wsj.com

(END) Dow Jones Newswires

December 08, 2025 04:17 ET (09:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2589333527"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2589333527\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2589333527?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 17:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589333527","market":"sg","top_or_hot":-1,"title":"L'Oreal Doubles Stake in Swiss Skincare Company Galderma","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Sarah Sloat \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology. \n</p>\n<p>\n  Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said. \n</p>\n<p>\n  The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. skincare brand, earlier this year. \n</p>\n<p>\n  The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion. \n</p>\n<p>\n  L'Oreal said it wasn't planning to further increase its stake. \n</p>\n<p>\n  Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table. \n</p>\n<p>\n  Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Sarah Sloat at sarah.sloat@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 04:17 ET (09:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>L'Oreal Doubles Stake in Swiss Skincare Company Galderma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nL'Oreal Doubles Stake in Swiss Skincare Company Galderma\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-08 17:17</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Sarah Sloat \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology. \n</p>\n<p>\n  Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said. \n</p>\n<p>\n  The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. skincare brand, earlier this year. \n</p>\n<p>\n  The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion. \n</p>\n<p>\n  L'Oreal said it wasn't planning to further increase its stake. \n</p>\n<p>\n  Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table. \n</p>\n<p>\n  Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Sarah Sloat at sarah.sloat@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 04:17 ET (09:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LRLCY","symbol_name":"欧莱雅","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2589333527","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589333527","pubTimestamp":1765185420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology.Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs  based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said.The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year.The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The com","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LRLCY":"欧莱雅","BK4183":"个人用品","BK6100":"保健护理服务"},"translate_title":"欧莱雅将瑞士护肤品公司Galderma的股份增加一倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NPL.SI":1.5,"LRLCY":0.9},"content_text":"By Sarah Sloat \n\n\n \n\n\n  L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology. \n\n\n  Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said. \n\n\n  The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year. \n\n\n  The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion. \n\n\n  L'Oreal said it wasn't planning to further increase its stake. \n\n\n  Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table. \n\n\n  Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT. \n\n\n \n\n\n  Write to Sarah Sloat at sarah.sloat@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 04:17 ET (09:17 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}